First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome

Prenatal Diagnosis

Volumn 29, Issue 13, 2009, Pages 1256-1261

  Pihl, Kasper ^a   Larsen, Torben ^b   Laursen, Inga ^a   Krebs, Lone ^b   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

First trimester; Preeclampsia; Pregnancy specific glycoprotein; Preterm delivery; SGA; SP1

Indexed keywords

BIOCHEMICAL MARKER; MAJOR BASIC PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROFORM OF EOSINOPHIL MAJOR BASIC PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; SMALL FOR DATE INFANT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EOSINOPHIL MAJOR BASIC PROTEIN; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; PREMATURE BIRTH; YOUNG ADULT;

EID: 73449116770     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2408     Document Type: Article

References (32)

1. Bohn H. 1972. Isolation and characterization of pregnancy-specific beta1-glycoprotein. Blut 24: 292-302.
2. Bohn H, Grudzinskas JG, Rosen S, et al. 1980. Reference preparation for assay of some pregnancy and cancer associated proteins. Lancet 2: 796.
3. Brown MA, Lindheimer MD, de SM, van AA, Moutquin JM. 2001. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV.
4. Chapman MG, O'Shea RT, Jones WR, Hillier R. 1981. Pregnancy-specific beta 1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol 141: 499-502.
5. Gardosi J, Francis A. 2007. Customised Centile Calculator - GROW-Centile v 5.12. Gestation Network, www.gestation.net.
6. Gordon YP, Grudzinskas JG, Jeffrey D, Chard T. 1977a. Concentrations of pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet 1: 331-333.
7. Gordon YB, Grudzinskas JG, Lewis JD, Jeffrey D, Letchworth AT. 1977b. Circulating levels of pregnancy-specific beta1-glycoprotein and human placental lactogen in the third trimester of pregnancy: their relationship to parity, birth weight, and placental weight. Br J Obstet Gynaecol 84: 642-647.
8. Graham GW, Crossley JA, Aitken DA, Connor JM. 1992. Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies. Prenat Diagn 12: 505-512.
9. Ha CT, Waterhouse R, Wessells J, Wu JA, Dveksler GS. 2005. Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE2, and TGF-beta1. J Leukoc Biol 77: 948-957.
10. Heinonen S, Taipale P, Saarikoski S. 2001. Weights of placentae from small-for-gestational age infants revisited. Placenta 22: 399-404.
11. Johnson MR, Riddle AF, Grudzinskas JG, Sharma V, Collins WP, Nicolaides KH. 1993. Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight. Hum Reprod 8: 1942-1947.
12. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S. 1974. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 118: 223-236.
13. Morris JK, Wald NJ. 2007. The effect of correlations between screening markers on screening performance. J Med Screen 14: 151-157.
14. Ness RB, Sibai BM. 2006. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195: 40-49.
15. Pihl K, Larsen T, Rasmussen S, Krebs L, Christiansen M. 2009. The proform of eosinophil major basic protein: a new maternal serum marker for adverse pregnancy outcome. Prenat Diagn. Epub ahead of print.
16. Qin QP, Christiansen M, Nguyen TH, Sorensen S, Larsen SO, Norgaard-Pedersen B. 1997. Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters. Prenat Diagn 17: 101-108.
17. Roberts JM, Hubel CA. 2009. The two stage model of pre-eclampsia: variations on the theme. Placenta 30(A): S32-S37.
18. Robinson HP, Fleming JE. 1975. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 82: 702-710.
19. Snyder SK, Wessner DH, Wessells JL, et al. 2001. Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am J Reprod Immunol 45: 205-216.
20. Tamsen L, Axelsson O, Johansson SG. 1983a. Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) in women with pregnancies at risk. Gynecol Obstet Invest 16: 253-260.
21. Tamsen L, Johansson SG, Axelsson O. 1983b. Pregnancy-specific beta 1-glycoprotein (SP1) in serum from women with pregnancies complicated by intrauterine growth retardation. J Perinat Med 11: 19-25.
22. Tatarinov I, Masiukevich VN. 1970. Immunochemical identification of a new beta-1-globulin in the serum of pregnant women. Biull Eksp Biol Med 69: 66-68.
23. Teglund S, Olsen A, Khan WN, Frangsmyr L, Hammarstrom S. 1994. The pregnancy-specific glycoprotein (PSG) gene cluster on human chromosome 19: fine structure of the 11 PSG genes and identification of 6 new genes forming a third subgroup within the carcinoembryonic antigen (CEA) family. Genomics 23: 669-684.
24. Towler CM, Horne CH, Jandial V, Campbell DM, MacGillivray I. 1977. Plasma levels of pregnancy-specific beta 1-glycoprotein in complicated pregnancies. Br J Obstet Gynaecol 84: 258-263.
25. Towler CM, Jandial V, Horne CH, Bohn H. 1976. A serial study of pregnancy proteins in primigravidae. Br J Obstet Gynaecol 83: 368-374.
26. Wald NJ, Watt HC, Norgaard-Pedersen B, Christiansen M, International Prenatal Screening Research Group. 1999. SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. Prenat Diagn 19: 517-520.
27. Westergaard JG, Teisner B, Hau J, Grudzinskas JG. 1984a. Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation. Br J Obstet Gynaecol 91: 1216-1223.
28. Westergaard JG, Teisner B, Hau J, Grudzinskas JG. 1984b. Placental protein measurements in complicated pregnancies. II. Pregnancy-related hypertension. Br J Obstet Gynaecol 91: 1224-1229.
29. Westergaard JG, Teisner B, Hau J, Grudzinskas JG. 1984c. Placental protein measurements in complicated pregnancies. III. Premature labour. Br J Obstet Gynaecol 91: 1230-1233.
30. Westergaard JG, Teisner B, Hau J, Grudzinskas JG, Chard T. 1985. Placental function studies in low birth weight infants with and without dysmaturity. Obstet Gynecol 65: 316-318.
31. Wurz H, Geiger W, Kunzig HJ, Jabs-Lehmann A, Bohn H, Luben G. 1981. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies. J Perinat Med 9: 67-78.
32. Zhou GQ, Baranov V, Zimmermann W, et al. 1997. Highly specific monoclonal antibody demonstrates that pregnancy-specific glycoprotein (PSG) is limited to syncytiotrophoblast in human early and term placenta. Placenta 18: 491-501.